LWMI
ALT icon

Legacy Wealth Management (Idaho)’s Altimmune ALT Stock Holding History

Legacy Wealth Management (Idaho)’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-250
Closed -$770 – 223
2026
Q1 		$770 Hold
250
– – ﹤0.01% 902
2025
Q4 		$903 Buy
+250
New +$1.09K ﹤0.01% 762

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Legacy Wealth Management (Idaho)'s ALT Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) sold out of Altimmune (ALT) in Q2 2026, closing a stake of 250 shares — an estimated $770 sold.

Legacy Wealth Management (Idaho) first reported a position in ALT in Q4 2025 and held it in 2 quarters. The position peaked at $903 in Q4 2025. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Legacy Wealth Management (Idaho) reported no remaining Altimmune position as of Q2 2026 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 250 Altimmune shares in Q2 2026, an estimated $770.
  • Legacy Wealth Management (Idaho) first reported a position in Altimmune in Q4 2025 and held it in 2 quarters.
  • Legacy Wealth Management (Idaho)'s Altimmune position peaked at $903 in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.